Cargando…

Persistent cutaneous lesion in a child with tyrosinemia: Esomeprazole‐induced lichenoid drug eruptions

Lichenoid drug eruptions (LDEs) are among well‐recognized adverse reactions that different drugs including Proton‐pump inhibitors (PPIs) are associated with. LDEs are rare adverse reaction of PPIs but they should be considered as appropriate management can lead to full resolution. Herein, we report...

Descripción completa

Detalles Bibliográficos
Autores principales: Abtahi‐Naeini, Bahareh, Saneian, Hossein, Dehghani, Shakiba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365549/
https://www.ncbi.nlm.nih.gov/pubmed/34429995
http://dx.doi.org/10.1002/ccr3.4610
_version_ 1783738730810441728
author Abtahi‐Naeini, Bahareh
Saneian, Hossein
Dehghani, Shakiba
author_facet Abtahi‐Naeini, Bahareh
Saneian, Hossein
Dehghani, Shakiba
author_sort Abtahi‐Naeini, Bahareh
collection PubMed
description Lichenoid drug eruptions (LDEs) are among well‐recognized adverse reactions that different drugs including Proton‐pump inhibitors (PPIs) are associated with. LDEs are rare adverse reaction of PPIs but they should be considered as appropriate management can lead to full resolution. Herein, we report a case of Esomeprazole‐induced LDE in a child with tyrosinemia.
format Online
Article
Text
id pubmed-8365549
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83655492021-08-23 Persistent cutaneous lesion in a child with tyrosinemia: Esomeprazole‐induced lichenoid drug eruptions Abtahi‐Naeini, Bahareh Saneian, Hossein Dehghani, Shakiba Clin Case Rep Case Reports Lichenoid drug eruptions (LDEs) are among well‐recognized adverse reactions that different drugs including Proton‐pump inhibitors (PPIs) are associated with. LDEs are rare adverse reaction of PPIs but they should be considered as appropriate management can lead to full resolution. Herein, we report a case of Esomeprazole‐induced LDE in a child with tyrosinemia. John Wiley and Sons Inc. 2021-08-16 /pmc/articles/PMC8365549/ /pubmed/34429995 http://dx.doi.org/10.1002/ccr3.4610 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Abtahi‐Naeini, Bahareh
Saneian, Hossein
Dehghani, Shakiba
Persistent cutaneous lesion in a child with tyrosinemia: Esomeprazole‐induced lichenoid drug eruptions
title Persistent cutaneous lesion in a child with tyrosinemia: Esomeprazole‐induced lichenoid drug eruptions
title_full Persistent cutaneous lesion in a child with tyrosinemia: Esomeprazole‐induced lichenoid drug eruptions
title_fullStr Persistent cutaneous lesion in a child with tyrosinemia: Esomeprazole‐induced lichenoid drug eruptions
title_full_unstemmed Persistent cutaneous lesion in a child with tyrosinemia: Esomeprazole‐induced lichenoid drug eruptions
title_short Persistent cutaneous lesion in a child with tyrosinemia: Esomeprazole‐induced lichenoid drug eruptions
title_sort persistent cutaneous lesion in a child with tyrosinemia: esomeprazole‐induced lichenoid drug eruptions
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365549/
https://www.ncbi.nlm.nih.gov/pubmed/34429995
http://dx.doi.org/10.1002/ccr3.4610
work_keys_str_mv AT abtahinaeinibahareh persistentcutaneouslesioninachildwithtyrosinemiaesomeprazoleinducedlichenoiddrugeruptions
AT saneianhossein persistentcutaneouslesioninachildwithtyrosinemiaesomeprazoleinducedlichenoiddrugeruptions
AT dehghanishakiba persistentcutaneouslesioninachildwithtyrosinemiaesomeprazoleinducedlichenoiddrugeruptions